참고문헌
- Amirnia M, Babaie-Ghazani A, Fakhrju A, et al (2012). Immunohistochemical study of cyclooxygenase-2 in skin tumors. J Dermatolog Treat, [Epub ahead of print].
- Atkins K (2011). p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL Papanicolaou cytology. Cancer Cytopathology, 119, 145-7. https://doi.org/10.1002/cncy.20139
- Baghiani Moghadam M (2003). Survey on knowledge, attitude and practice of 15-49 years age group married women related to Pap smear test in Yazd city in 2001. J Mazandaran University of Medical Sciences, 13, 79-85.
- Boon ME, Vinkestein A, van Binsbergen-Ingelse A, van Haaften C (2004). Significance of MiB-1 staining in smears with atypical glandular cells. Diagnostic Cytopathology, 31, 77-82. https://doi.org/10.1002/dc.20043
- BBosch FX, Lorincz A, Munoz N, et al (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol, 55, 244-65. https://doi.org/10.1136/jcp.55.4.244
- Brown D, Gatter K (2002). Ki67 protein: the immaculate deception? Histopathology, 40, 2-11. https://doi.org/10.1046/j.1365-2559.2002.01343.x
- Bulten J, de Wilde PC, Boonstra H, Gemmink JH, Hanselaar AG (2000). Proliferation in "atypical" atrophic Pap smears. Gynecol Oncol, 79, 225-9. https://doi.org/10.1006/gyno.2000.5943
- Bulten JP, de Wilde P, Boonstra H, et al (2000). Decreased expression of Ki-67 in atrophic cervical epithelium of post-menopausal women. J Pathol, 190, 545-53. https://doi.org/10.1002/(SICI)1096-9896(200004)190:5<545::AID-PATH549>3.0.CO;2-S
- Davey DD, Zarbo RJ (2003). Introduction and commentary, Strategic Science Symposium: human papillomavirus testing-are you ready for a new era in cervical cancer screening? Arch Pathol Lab Med, 127, 927-9.
- Do H, Seng P, Talbot J, et al (2009). HPV vaccine knowledge and beliefs among Cambodian American parents and community leaders. Asian Pac J Cancer Prev, 10, 339-44.
- Ejersbo D, Jensen H, Holund B, et al (1999). Efficacy of Ki-67 antigen staining in Papanicolaou (Pap) smears in pos-menopausal women with atypia-an audit. Cytopathology, 10, 369-74. https://doi.org/10.1046/j.1365-2303.1999.00205.x
- Gertych A, Joseph AO, Walts AE, et al (2012). Automated detection of dual p16/Ki67 nuclear immunoreactivity in liquid-based pap tests for improved cervical cancer risk stratification. Annals of Biomedical Engineering, 40, 1192-204. https://doi.org/10.1007/s10439-011-0498-8
- Ghojazadeh M, Azar ZF, Saleh P, et al (2012). Knowledge and attitude of iranian university students toward human papilloma virus. Asian Pac J Cancer Prev, 13, 6115-9. https://doi.org/10.7314/APJCP.2012.13.12.6115
- Ghojazadeh M, Naghavi-Behzad M, Azar ZF, et al (2012). Parental knowledge and attitudes about human papilloma virus in Iran. Asian Pac J Cancer Prev, 13, 6169-73. https://doi.org/10.7314/APJCP.2012.13.12.6169
- Ghojazadeh M, Mohammadi M, Azami-Aghdash S, et al (2013). Estimation of cancer cases using capture-recapture method in Northwest Iran. Asian Pac J Cancer Prev, 14, 3237-41. https://doi.org/10.7314/APJCP.2013.14.5.3237
- Gibbs RS, Danforth DN (2008). Danforth's obstetrics and gynecology, Lippincott Williams & Wilkins.
- Goel M, Mehrotra A, Singh U, et al (2005). MIB-1 and PCNA immunostaining as a diagnostic adjunct to cervical pap smear. Diagnostic Cytopathology, 33, 15-9. https://doi.org/10.1002/dc.20218
- Gupta N, Rajwanshi A (2013). Gynecological cancers: pathology and cytological methods for diagnosis of gynecological cancers. In 'Breast and Gynecological Cancers'
- Hanprasertpong J, Tungsinmunkong K, Chichareon S, et al (2010). Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas. J Obstet Gynaecol Res, 36, 572-80. https://doi.org/10.1111/j.1447-0756.2010.01227.x
- Jackson JA, Kapur U, Ersahin C, et al (2012). Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3-to 7-year follow-up. Int J Surg Pathol, 20, 144-51. https://doi.org/10.1177/1066896911427703
- Keating JT, Cviko A, Riethdorf S, et al (2001). Ki-67, cyclin E, and p16 INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol, 25, 884-91. https://doi.org/10.1097/00000478-200107000-00006
- Mimica M, Tomic S, Kardum G, et al (2010). Ki-67 quantitative evaluation as a marker of cervical intraepithelial neoplasia and human papillomavirus infection. Int J Gynecol Cancer, 20, 116-9. https://doi.org/10.1111/IGC.0b013e3181bc8da7
- Moore MA, Tajima K (2004). Cervical cancer in the Asian Pacific-epidemiology, screening and treatment. Asian Pac J Cancer Prev, 5, 349-61.
- Munoz N, Bosch FX, de Samjose S, et al (2003). Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med, 348, 518-27. https://doi.org/10.1056/NEJMoa021641
- Pahuja S, Choudhury M, Gupta U, et al (2004). Ki-67 immunostaining in Pap smears of cervix: assessment of proliferation in preinvasive and invasive squamous epithelial lesions. Indian J Pathol Microbiol, 47, 1-3.
- Petry KU, Schmidt D, Scherbring S, et al (2011). Triaging pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 dual-stained cytology. Gynecol Oncol, 121, 505-9. https://doi.org/10.1016/j.ygyno.2011.02.033
- Qiao X, Bhuiya TA, Spitzer M, et al (2005). Differentiating high-grade cervical intraepithelial lesion from atrophy in postmenopausal women using Ki-67, cyclin E, and p16 immunohistochemical analysis. J Low Genit Tract Dis, 9, 100-7. https://doi.org/10.1097/00128360-200504000-00006
- Samir R, Asplund A, Tot T, et al (2011). High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a. J Low Genit Tract Dis, 15, 280-6. https://doi.org/10.1097/LGT.0b013e318215170c
- Siemens FC, van Haaften C, van Haaften C, et al (2011). Progression of abnormal MIB-1 staining patterns of reserve cells in cervical smears from women ultimately developing high grade squamous intraepithelial lesions. Acta Cytol 50, 637-42.
- Smedts F (2001). Efficacy of Ki-67 antigen staining in Papanicolaou (pap) smears in postmenopausal women with atypia-an audit. Cytopathology, 12, 130-2. https://doi.org/10.1046/j.1365-2303.2001.0293c.x
- Son SM, Noh KI, Lee HC, et al (2012). Evaluation of p16INk4a, pRb, p53 and Ki-67 expression in cervical squamous neoplasia. Cell Cycle, 5, 6.
- Vu LT, Bui D (2012). Prevalence of cervical human papilloma virus infection among married women in Vietnam, 2011. Asian Pac J Cancer Prev, 13, 37-40. https://doi.org/10.7314/APJCP.2012.13.1.037
- Wong F (2010). Immunohistochemical detection of proliferating tumor cells in cervical cancer using monoclonal antibody Ki-67. Gynecol Obstet Inves, 37, 123-6.
- Zhang HY, Tiggelaar SM, Sahasrabuddhe VV, et al (2012). HPV prevalence and cervical intraepithelial neoplasia among HIV-infected women in Yunnan Province, China: a pilot study. Asian Pac J Cancer Prev, 13, 91-6. https://doi.org/10.7314/APJCP.2012.13.1.091
피인용 문헌
- Knowledge Production Status of Iranian Researchers in the Gastric Cancer Area: Based on the Medline Database vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.5083
- Ki-67/MIB-1 as a Prognostic Marker in Cervical Cancer - a Systematic Review with Meta-Analysis vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.6997
- Ki-67 is a Valuable Prognostic Factor in Gliomas: Evidence from a Systematic Review and Meta-analysis vol.16, pp.2, 2015, https://doi.org/10.7314/APJCP.2015.16.2.411
- Comparative Study of Dermatoscopic and Histopathologic Results in Facial Basal Cell Carcinoma and Melanocytic Nevi vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.425